{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:34:08Z","timestamp":1790685248399,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.addbeh.2022.107360","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T18:21:31Z","timestamp":1651947691000},"page":"107360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Cannabidiol in the context of substance use disorder treatment: A systematic review"],"prefix":"10.1016","volume":"132","author":[{"given":"Victoria","family":"Paulus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Billieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Karila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.10.040","article-title":"Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling","volume":"131","author":"Balla","year":"2018","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.addbeh.2022.107360_b0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"The American Psychologist"},{"issue":"10","key":"10.1016\/j.addbeh.2022.107360_b0025","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1002\/ptr.7232","article-title":"The emerging role of cannabidiol (CBD) products; a survey exploring the public\u2019s use and perceptions of CBD","volume":"35","author":"Bhamra","year":"2021","journal-title":"Phytotherapy Research: PTR"},{"issue":"6","key":"10.1016\/j.addbeh.2022.107360_b0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/npp.2014.258","article-title":"Cannabinoid modulation of functional connectivity within regions processing attentional salience","volume":"40","author":"Bhattacharyya","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.addbeh.2022.107360_b0035","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881120965952","article-title":"Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice","volume":"35","author":"Calpe-L\u00f3pez","year":"2021","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"5 Suppl 3","key":"10.1016\/j.addbeh.2022.107360_b0045","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2146\/ajhp060647","article-title":"Understanding the health impact of alcohol dependence","volume":"64","author":"Cargiulo","year":"2007","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"12","key":"10.1016\/j.addbeh.2022.107360_b0050","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder: A systematic review and meta-analysis","volume":"34","author":"Chan","year":"2019","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.addbeh.2022.107360_b0055","article-title":"Treatment interventions to maintain abstinence from alcohol in primary care: Systematic review and network meta-analysis","volume":"371","author":"Cheng","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.addbeh.2022.107360_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320954992","article-title":"Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products","volume":"10","author":"Chesney","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"11","key":"10.1016\/j.addbeh.2022.107360_b0065","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: A systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173065","article-title":"Cannabidiol (CBD) reduces cocaine-environment memory in mice","volume":"199","author":"Chesworth","year":"2020","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"50","key":"10.1016\/j.addbeh.2022.107360_b0075","first-page":"4360","article-title":"A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant","volume":"169","author":"Christensen","year":"2007","journal-title":"Ugeskrift for Laeger"},{"issue":"5\u20136","key":"10.1016\/j.addbeh.2022.107360_b0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behavioural Pharmacology"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/oxfordjournals.alcalc.a008368","article-title":"Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716","volume":"33","author":"Colombo","year":"1998","journal-title":"Alcohol and Alcoholism"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002130100887","article-title":"Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats","volume":"159","author":"Colombo","year":"2002","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00431988","article-title":"Interaction of cannabidiol and alcohol in humans","volume":"66","author":"Consroe","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: A case report: CBD and cannabis withdrawal","volume":"38","author":"Crippa","year":"2013","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats: CBD impairs CPP and CPA","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addiction Biology"},{"issue":"9810","key":"10.1016\/j.addbeh.2022.107360_b0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107360_b0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.addbeh.2022.107360_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfca.2020.103800","article-title":"A survey of cannabinoids and toxic elements in hemp-derived products from the United States marketplace","volume":"97","author":"Dubrow","year":"2021","journal-title":"Journal of Food Composition and Analysis"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.addbeh.2022.107360_b0130","article-title":"A gender perspective of addictive disorders","volume":"1\u201311","author":"Fonseca","year":"2021","journal-title":"Current Addiction Reports"},{"issue":"10","key":"10.1016\/j.addbeh.2022.107360_b0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: A phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107360_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.seizure.2020.09.010","article-title":"Interaction of cannabidiol with other antiseizure medications: A narrative review","volume":"86","author":"Gilmartin","year":"2021","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.addbeh.2022.107360_b0150","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: Preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.neubiorev.2008.08.008","article-title":"Poor response inhibition: At the nexus between substance abuse and attention deficit\/hyperactivity disorder","volume":"33","author":"Groman","year":"2009","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"12","key":"10.1016\/j.addbeh.2022.107360_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw068","article-title":"The CB1 neutral antagonist AM4113 retains the therapeutic efficacy of the inverse agonist rimonabant for nicotine dependence and weight loss with better psychiatric tolerability","volume":"19","author":"Gueye","year":"2016","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.addbeh.2022.107360_b0165","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2007.09.090","article-title":"Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism","volume":"1188","author":"Hayakawa","year":"2008","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41401-018-0059-x","article-title":"Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats","volume":"40","author":"He","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"issue":"9","key":"10.1016\/j.addbeh.2022.107360_b0180","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/add.14243","article-title":"Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal","volume":"113","author":"Hindocha","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0185","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1038\/s41598-018-25846-2","article-title":"The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers","volume":"8","author":"Hindocha","year":"2018","journal-title":"Scientific Reports"},{"issue":"4175","key":"10.1016\/j.addbeh.2022.107360_b0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.1167428","article-title":"Morphine-dependent rats: Blockade of precipitated abstinence by tetrahydrocannabinol","volume":"187","author":"Hine","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0195","first-page":"185","article-title":"Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats","volume":"12","author":"Hine","year":"1975","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"issue":"11","key":"10.1016\/j.addbeh.2022.107360_b0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107360_b0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: Opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.addbeh.2022.107360_b0210","doi-asserted-by":"crossref","unstructured":"Karimi\u2010Haghighi, S., Dargahi, L., & Haghparast, A. (2020). Cannabidiol modulates the expression of neuroinflammatory factors in stress\u2010 and drug\u2010induced reinstatement of methamphetamine in extinguished rats. Addiction Biology, 25(2), Article e12740. 10.1111\/adb.12740.","DOI":"10.1111\/adb.12740"},{"key":"10.1016\/j.addbeh.2022.107360_b0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pnpbp.2017.08.022","article-title":"Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats","volume":"82","author":"Karimi-Haghighi","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.2010.318","article-title":"Subjective and physiological effects after controlled Sativex and oral THC administration","volume":"89","author":"Karschner","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.addbeh.2022.107360_b0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2020.11.021","article-title":"Cannabidiol attenuated the maintenance and reinstatement of extinguished methylphenidate-induced conditioned place preference in rats","volume":"166","author":"Kashefi","year":"2021","journal-title":"Brain Research Bulletin"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: Involvement of 5-HT 1A receptors in the dorsal raphe nucleus: Cannabidiol and brain reward","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addiction Biology"},{"key":"10.1016\/j.addbeh.2022.107360_b0235","doi-asserted-by":"crossref","unstructured":"Khoury, J. M., Neves, M. de C. L. das, Roque, M. A. V., Queiroz, D. A. de B., Corr\u00eaa de Freitas, A. A., de F\u00e1tima, \u00c2., Moreira, F. A., & Garcia, F. D. (2019). Is there a role for cannabidiol in psychiatry? The World Journal of Biological Psychiatry\\, 20(2), 101\u2013116. 10.1080\/15622975.2017.1285049.","DOI":"10.1080\/15622975.2017.1285049"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0240","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates \u03949-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.addbeh.2022.107360_b0245","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: A neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"The Lancet. Psychiatry"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40211-020-00334-0","article-title":"Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression","volume":"35","author":"Laczkovics","year":"2020","journal-title":"Neuropsychiatrie"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14740\/jocmr4090","article-title":"Dosage, efficacy and safety of cannabidiol administration in adults: A systematic review of human trials","volume":"12","author":"Larsen","year":"2020","journal-title":"Journal of Clinical Medicine Research"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0260","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.addbeh.2022.107360_b0265","doi-asserted-by":"crossref","unstructured":"Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimar\u00e3es, F. S., & Crippa, J. A. (2019). Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil: 1999), 41(1), 9\u201314. 10.1590\/1516-4446-2017-0015.","DOI":"10.1590\/1516-4446-2017-0015"},{"key":"10.1016\/j.addbeh.2022.107360_b0270","doi-asserted-by":"crossref","unstructured":"Luj\u00e1n, M. \u00c1., Cantacorps, L., & Valverde, O. (2020). The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake. Addiction Biology, 25(4), Article e12778. 10.1111\/adb.12778.","DOI":"10.1111\/adb.12778"},{"key":"10.1016\/j.addbeh.2022.107360_b0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0280","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0000000000000118","article-title":"Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans","volume":"9","author":"Manini","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"04","key":"10.1016\/j.addbeh.2022.107360_b0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0043-117838","article-title":"Effects of cannabidiol on morphine conditioned place preference in mice","volume":"84","author":"Markos","year":"2018","journal-title":"Planta Medica"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107360_b0300","unstructured":"Meneses-Gaya, C. de, Crippa, J. A., Hallak, J. E., Miguel, A. Q., Laranjeira, R., Bressan, R. A., Zuardi, A. W., & Lacerda, A. L. (2020). Cannabidiol for the treatment of crack-cocaine craving: An exploratory double-blind study. Brazilian Journal of Psychiatry, S1516-44462020005037203. 10.1590\/1516-4446-2020-1416."},{"key":"10.1016\/j.addbeh.2022.107360_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0310","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), Article e1000097. 10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"9","key":"10.1016\/j.addbeh.2022.107360_b0315","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/add.15417","article-title":"Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: A randomized placebo-controlled trial","volume":"116","author":"Mongeau-P\u00e9russe","year":"2021","journal-title":"Addiction (Abingdon, England)"},{"issue":"9","key":"10.1016\/j.addbeh.2022.107360_b0320","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol attenuates the appetitive effects of \u03949-tetrahydrocannabinol in humans smoking their chosen cannabis","volume":"35","author":"Morgan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107360_b0325","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"British Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.addbeh.2022.107360_b0330","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.addbeh.2022.107360_b0335","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","article-title":"Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract","volume":"27","author":"Nadulski","year":"2005","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.addbeh.2022.107360_b0340","first-page":"CD008940","article-title":"Pharmacotherapies for cannabis dependence","volume":"1","author":"Nielsen","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0350","doi-asserted-by":"crossref","unstructured":"Rainer Spanagel. (2020). Cannabinoids and the endocannabinoid system in reward processing and addiction: From mechanisms to interventions. Dialogues in Clinical Neuroscience, 22(3), 241\u2013250. 10.31887\/DCNS.2020.22.3\/rspanagel.","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel"},{"key":"10.1016\/j.addbeh.2022.107360_b0355","series-title":"The Wiley-Blackwell handbook of addiction psychopharmacology","first-page":"345","article-title":"The assessment of craving in addiction research","author":"Ray","year":"2013"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107360_b0360","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/FBP.0000000000000544","article-title":"Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats","volume":"31","author":"Razavi","year":"2020","journal-title":"Behavioural Pharmacology"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107360_b0365","first-page":"135","article-title":"The risks associated with alcohol use and alcoholism","volume":"34","author":"Rehm","year":"2011","journal-title":"Alcohol Research & Health"},{"issue":"47","key":"10.1016\/j.addbeh.2022.107360_b0370","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"Journal of Neuroscience"},{"issue":"18","key":"10.1016\/j.addbeh.2022.107360_b0375","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/j.addbeh.2022.107360_b0380","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochemical Research"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0385","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hup.1196","article-title":"A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use","volume":"26","author":"Schoedel","year":"2011","journal-title":"Human Psychopharmacology"},{"issue":"6","key":"10.1016\/j.addbeh.2022.107360_b0390","first-page":"31","article-title":"Cannabidiol oil for decreasing addictive use of marijuana: A case report","volume":"14","author":"Shannon","year":"2015","journal-title":"Integrative Medicine"},{"key":"10.1016\/j.addbeh.2022.107360_b0395","doi-asserted-by":"crossref","unstructured":"Shiels, M. S., Freedman, N. D., Thomas, D., & Berrington de Gonzalez, A. (2018). Trends in U.S. drug overdose deaths in non-Hispanic black, Hispanic, and non-Hispanic white persons, 2000-2015. Annals of Internal Medicine, 168(6), 453\u2013455. 10.7326\/M17-1812.","DOI":"10.7326\/M17-1812"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_bib476","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropsychologia.2007.07.015","article-title":"Meta-analysis of Go\/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent.","volume":"46","author":"Simmonds","year":"2008","journal-title":"Neuropsychologia"},{"issue":"5","key":"10.1016\/j.addbeh.2022.107360_b0400","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0405","unstructured":"United Nations Office on Drugs and Crime. (2021). World drug report (No. E.21.XI.8). https:\/\/wdr.unodc.org\/wdr2020\/en\/index.html."},{"issue":"1\u20133","key":"10.1016\/j.addbeh.2022.107360_b0410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of \u03949-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"16","key":"10.1016\/j.addbeh.2022.107360_b0415","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of cannabidiol plus naltrexone on motivation and ethanol consumption: Cannabidiol and naltrexone in alcohol use disorder","volume":"175","author":"Viudez-Mart\u00ednez","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.addbeh.2022.107360_b0420","doi-asserted-by":"crossref","unstructured":"Viudez\u2010Mart\u00ednez, A., Garc\u00eda\u2010Guti\u00e9rrez, M. S., & Manzanares, J. (2020). Gender differences in the effects of cannabidiol on ethanol binge drinking in mice. Addiction Biology, 25(3), Article e12765. 10.1111\/adb.12765.","DOI":"10.1111\/adb.12765"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0425","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice: Cannabidiol and AUD","volume":"23","author":"Viudez-Mart\u00ednez","year":"2018","journal-title":"Addiction Biology"},{"issue":"7","key":"10.1016\/j.addbeh.2022.107360_b0430","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145708008717","article-title":"Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine","volume":"11","author":"Vlachou","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13148-020-00993-4","article-title":"Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice","volume":"13","author":"Wanner","year":"2021","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.addbeh.2022.107360_b0440","unstructured":"World Health Organization. (2015). Expanding public health approaches to the world drug problem. https:\/\/www.who.int\/substance_abuse\/ungass-leaflet.pdf?ua=1."},{"key":"10.1016\/j.addbeh.2022.107360_b0445","unstructured":"World Health Organization. (2018). Cannabidiol (CBD)\u2014Critical review report. https:\/\/www.who.int\/medicines\/access\/controlled-substances\/CannabidiolCriticalReview.pdf."},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0450","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/can.2019.0052","article-title":"Use of cannabidiol for the treatment of anxiety: A short synthesis of pre-clinical and clinical evidence","volume":"5","author":"Wright","year":"2020","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"15\u201316","key":"10.1016\/j.addbeh.2022.107360_b0455","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.lfs.2011.02.017","article-title":"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety","volume":"88","author":"Yamaori","year":"2011","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0460","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxres\/tfaa021","article-title":"Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R\/AKT\/GSK-3\u03b2\/CREB signaling pathway in rats","volume":"9","author":"Yang","year":"2020","journal-title":"Toxicology Research"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107360_b0465","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107360_b0470","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11481-018-9782-9","article-title":"Cannabis addiction and the brain: A review","volume":"13","author":"Zehra","year":"2018","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107360_b0475","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460322001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460322001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:49:21Z","timestamp":1759690161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460322001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":95,"alternative-id":["S0306460322001265"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2022.107360","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol in the context of substance use disorder treatment: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2022.107360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107360"}}